Vincerx Pharma is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by a third party service, and Vincera Pharma, Inc. does not maintain or provide information directly to this service.
May 11, 2023
Apr 19, 2023
Apr 17, 2023
Feb 16, 2023 at 1:40 PM EST
Feb 17, 2022 at 1:40 PM EST
Dec 11, 2021 at 7:30 PM EST